NASDAQ: IMUXImmunic Inc Stock Ownership - Who owns Immunic?
Insider buying vs selling
Have Immunic Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jason Tardio | President and COO | 2025-06-05 | 12,512 | $0.79 | $9.88kBuy |
| Joerg Neermann | Director | 2025-06-05 | 30,000 | $0.76 | $22.80kBuy |
| Joerg Neermann | Director | 2025-06-04 | 70,000 | $0.77 | $53.90kBuy |
| Daniel Vitt | CEO and Director | 2025-06-04 | 15,000 | $0.77 | $11.55kBuy |
| Glenn Whaley | Chief Financial Officer | 2025-06-03 | 45,000 | $0.71 | $32.09kBuy |
| Richard Alan Rudick | Director | 2025-06-03 | 143,075 | $0.70 | $100.01kBuy |
| Glenn Whaley | Chief Financial Officer | 2025-05-30 | 25,000 | $0.56 | $14.00kBuy |
| Richard Alan Rudick | Director | 2024-11-12 | 87,300 | $1.15 | $100.39kBuy |
IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMUX insiders and whales buy or sell their stock.
IMUX Shareholders
What type of owners hold Immunic Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Inc | 9.29% | 8,902,972 | $7.17M | Institution |
| Soleus Capital Management LP | 7.61% | 7,293,007 | $5.87M | Institution |
| Muneer A. Satter | 7.44% | 7,132,277 | $5.74M | Insider |
| Avidity Partners Management LP | 4.65% | 4,454,408 | $3.59M | Institution |
| Vanguard Group Inc | 4.10% | 3,931,548 | $3.16M | Institution |
| Focus Partners Wealth | 2.70% | 2,583,457 | $2.08M | Institution |
| V. Cooperatieve Ua Lsp | 2.26% | 2,162,782 | $1.74M | Insider |
| Omega Fund Management LLC | 1.87% | 1,788,160 | $1.44M | Institution |
| Adage Capital Partners GP LLC | 1.46% | 1,398,600 | $1.13M | Institution |
| Life Bioventure V. Sarl Global | 1.43% | 1,371,494 | $1.10M | Insider |
IMUX vs Biotech Stocks
Immunic Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.